PRNewswire: June 14, 2017 – CHAPEL HILL, NC, U.S.A. – Achelios Therapeutics, a privately held pharmaceutical development company focused on innovative topical drug delivery technologies, announced today it has completed a Type C meeting with the FDA regarding a path to approval for TOPOFEN™ in…
